| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.68B | -0.9% |
| Cost of Revenue | $6.99B | -2.1% |
| Gross Profit | $2.68B | +2.6% |
| R&D Expense | $123.0M | +16.0% |
| Operating Income | $1.81B | +5.7% |
| Interest Expense | $76.0M | -30.3% |
| Pre-tax Income | $1.59B | -1.4% |
| Income Tax | $401.0M | +7.5% |
| Net Income | $1.20B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.61B | +47.0% |
| Accounts Receivable | $987.0M | +2.7% |
| Inventory | $1.20B | -10.2% |
| Current Assets | $3.92B | +10.2% |
| Total Assets | $11.24B | +4.5% |
| Current Liabilities | $2.32B | +10.5% |
| Long-term Debt | $3.05B | +0.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.72B | -2.3% |
| Investing Cash Flow | -$356.0M | +42.9% |
| Financing Cash Flow | -$877.0M | +10.0% |
| -3.6% |
| EPS (Basic) | $13.27 | +3.3% |
| EPS (Diluted) | $13.14 | +3.5% |
| Total Liabilities |
| $6.03B |
| -1.7% |
| Stockholders' Equity | $5.17B | +12.9% |